Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Plos One|October 24, 2019
Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in FranceAnne Cowppli-Bony, Brigitte Trétarre, Emilie Marrer, et al.International Journal of Epidemiology|August 25, 2020
Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimatesZoé Uhry, Edouard Chatignoux, Emmanuelle Dantony, et al.Cancer Epidemiology|March 4, 2020
Cancer risk in dialyzed patients with and without diabetesAdélaïde Pladys, Gautier Defossez, Pierre Lemordant, et al.Pharmacoepidemiology and Drug Safety|October 26, 2023
Validation of an algorithm for identifying incident cancer cases based on long-term illness and diagnosis related group program data from the French National Health Insurance Information System (SNDS)Hélène Goulard, Julie Homère, Sylvain Maurisset, et al.Journal of Clinical Medicine|February 11, 2023
Evolution of the Incidence of Oral Cavity Cancers in the Elderly from 1990 to 2018Alice Renou, Anne-Valérie Guizard, Emilien Chabrillac, et al.European Journal of Cancer (Oxford, England : 1990)|November 13, 2019
Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in FranceChantal Barin-Le Guellec, Claire Lafay-Chebassier, Isabelle Ingrand, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 5, 2023
Net survival in colon and rectal cancer by stage according to neoadjuvant treatment. A French population-based studyValérie Jooste, Pascale Grosclaude, Gautier Defossez, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 26, 2023
Trends in incidence of invasive vaginal cancer in France from 1990 to 2018 and survival of recently diagnosed women - A population-based studyBrigitte Trétarre, Emmanuelle Dantony, Gaëlle Coureau, et al.Blood Advances|August 27, 2025
Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomideThomas Systchenko, Ialy Nsiala, Arthur Bobin, et al.Pageof 4